MedTrace Logo

Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients

NCT03999411 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-03-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn if a mindfulness-based smoking cessation smartphone app can help people quit smoking and stay on antiretroviral therapies.

Conditions

  • Smoking
  • Smoking Cessation
  • HIV

Interventions

DRUG

Nicoderm C-Q Transdermal Product

6 weeks of GlaxoSmithKline Nicoderm CQ (NRT)

BEHAVIORAL

Adherence to Antiretroviral Therapy Counseling

Brief counseling on adhering to antiretroviral therapy with self-help materials.

BEHAVIORAL

Behavioral Smoking Cessation Counseling

One time face-to-face smoking cessation counseling and 2 follow-up phone calls.

BEHAVIORAL

"Crave-to-Quit" app

Evidence-based mindfulness smoking cessation smartphone app ("Crave-to-Quit") adapted from an in-person mindfulness training relapse prevention smoking cessation intervention.

BEHAVIORAL

vDOT "emocha" app

Video Directly Observed Therapy (vDOT) smartphone app ("emocha") that allows participants to take a video of themselves taking medication to ensure adherence.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Taghrid Asfar, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2020-10-14
Completion
2020-10-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03999411 on ClinicalTrials.gov